Introduction
Non-invasive ventilation (NIV) aims to improve arterial blood gases (ABGs) in patients with hypercapnic respiratory failure. Monitoring of NIV outside of an intensive care unit (ICU) requires measuring ABGs by arterial puncture, to ensure that NIV improves daytime hypoxia and hypercapnia. However, daytime ABG measurements may poorly reflect the quality of ventilation during sleep (1) . Pulse oximetry is valuable for adjusting FiO 2 , and may be helpful in detecting desaturations related to air leaks, ventilation-perfusion mismatch or hypoventilation, although it may be of limited value in patients under oxygen and NIV. Monitoring of arterial carbon dioxide (CO 2 ) is necessary to detect either nocturnal hyperventilation or hypoventilation (1, 2) . Measuring transcutaneous PO 2 has been described as unreliable for clinical use in adults (1, 2) , but transcutaneous measurement of CO 2 (TcPCO 2 ) is well correlated with arterial measurements (3) . There are however a few reported drawbacks to the method such as the necessity of changing the skin site of the probe after 4 h and recalibrating, to avoid skin burning (a time-consuming procedure) (3, 4) .
Although used in previous publications for overnight studies (5) (6) (7) (8) , TcPCO 2 monitoring has never been validated for continuous 8-h monitoring. The present study aims to show whether TcPCO 2 recordings can be performed continuously for 8 h, at a low electrode temperature of 438C, without recalibration, without any local side-effects, without any significant alteration in the relationship between TcPCO 2 and PaCO 2 , or any significant drift of the TcPCO 2 signal.
Patients and methods
Patients treated by NIV for acute or chronic respiratory failure at our institution were considered for the present study. To be included, they had to be haemodynamically stable (systolic blood pressure 4100 mmHg and diastolic blood pressure 460 mmHg), without any vasopressor treatment, and willing to participate to the study protocol.
Transcutaneous measurements were performed using a Radiometer Tina TCM3 capnograph (Radiometer 1 , Copenhagen, Denmark) with a combined TcPO 2 (type Clark)/ TcPCO 2 (type Stow-Severinghaus) electrode (model E5280). The principle of the electrode has been previously described (2) . Calibration of the electrode was performed before each new measurement, with a standard (5% CO 2 -20?9% O 2 ) calibration gas. The electrode was positioned on the anterior chest wall, as suggested by the manufacturer, after thoroughly cleansing the skin with alcohol. Care was taken to avoid bony prominences, visible veins or any other interference with skin perfusion. The temperature of the electrode was set at 438C: this induces a local hyperaemia which improves the permeability of the skin to gas diffusion, and 'arterializes' the capillary blood to obtain TcPCO 2 readings closer to PaCO 2 values, without inducing local skin reactions or skin burns. This temperature is lower than the recommended 44-458C. The manufacturer suggests changing the site of the electrode every 4 h (and recalibrating). However, patient tolerance to 5 h of continuous monitoring (i.e. without changing the position of the probe) with the same electrode and capnograph, at 438C, has been reported (9) . Arterial blood gases (ABGs) were determined with a gas analyser (ABL 520; Radiometer 1 ; Copenhagen, Denmark).
CORRELATIONS BETWEEN ARTERIAL AND TRANSCUTANEOUS VALUES OF PCO 2 AND PO 2 AT 438C
A 20-min period was required to allow for stabilization of the signal before performing ABG measurements. After this period, arterial blood samples for ABG determination were obtained by puncture of the radial artery. Twenty-eight patients were studied.
DRIFT OF TCPCO 2 OVER AN 8-H CONTINUOUS RECORDING
In 10 patients who accepted serial arterial punctures, arterial blood samples were taken at the beginning of the TcPCO 2 monitoring (after allowing for stabilization of signal), after 4 h and 8 h of continuous TcPCO 2 monitoring (8 h is the maximal recording capacity of the capnograph tested). All arterial measurements were performed in steady state situations (i.e. patients had been with or without noninvasive ventilation for at least 30 min, and transcutaneous signals were stable), to take into account the lag time of the capnograph (an estimation of the lag time, i.e. the time occurring between a change in PaCO 2 and it's transcutaneous recording is 5+3 min; range: 1-9 min) (3). 
STATISTICAL ANALYSIS

Results
PATIENTS
Twenty-eight patients (18 male, 10 female; age 69+9 years, range, 46-85 years), treated by intermittent NIV, were studied. Diagnoses included COPD (n=16), obesityhypoventilation syndrome (n=5), neuromuscular disorders (n=2), sequelae of tuberculosis (n=2), severe kyphoscoliosis (n=2) and pneumoconiosis (n=1 Fig. 2 ). The best TcPCO 2 readings (i.e. TcPCO 2 -PaCO 2 within d+2 mmHg) were obtained between 40 and 54 mmHg; below and above these values, the TcPCO 2 -PaCO 2 gradient increased (Fig. 2) .
No significant correlation was found between the TcPCO 2 -PaCO 2 gradient and BMI, age, or any of the functional parameters recorded (FEV 1 , FVC, FEV 1 /FVC 
DRIFT OF TcPCO 2 SIGNAL OVER 8 H
For the 10 patients tested over 8 h, the mean values for TcPCO 2 -PaCO 2 were, at t=0: 5?7+3?8 mmHg; at t=4 h: 2?1+3?9 mmHg and at t=8 h: 2?0+5?2 mmHg. Mean TcPCO 2 -PaCO 2 actually decreased over the 8-h observation period; these changes over time were however not significant (ANOVA for repeated measurements, P=0?08; Fig. 3) . No local discomfort, burn or blister occurred after 8 h.
Discussion
The present study shows that TcPCO 2 can be measured continuously for 8 h in adults at a probe temperature of 438C without recalibration or changing skin probe position, while maintaining a highly significant correlation between PaCO 2 and TcPCO 2, without any discomfort for the patient, and with no significant drift or deterioration in the TcPCO 2 signal.
PERFORMANCE OF THE CAPNOGRAPH AT DIFFERENT ELECTRODE TEMPERATURES
The lowest reported electrode temperature used for monitoring TcPCO 2 with a Radiometer TCM-3 capnograph is, to our knowledge, 428C; however, correlation with PaCO 2 was not reported (12) . Albeit for the study by Rosner et al. Table 1) . Despite a lower probe temperature, correlation coefficients obtained in the present study are higher than previously published data (4, (13) (14) (15) ; precision and limits of agreement in the present study are similar to published values obtained at 448C with the same capnograph (15) . Although Sridhar et al. showed that increasing probe temperature to 458C significantly increases the accuracy and precision of TcPO 2 and TcPCO 2 measurements, this probe temperature cannot be used for several hours (16) ( Table 1) .
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The reason for the higher bias and wider limits of agreement in the study by Rosner et al. is unclear; particular attention was taken in the present study to recalibrate the capnograph before each new patient, to thoroughly cleanse the skin with alcohol, and to allow for stabilization of the TcPCO 2 signal: indeed, time for TcPCO 2 signal to stabilize increases at lower electrode temperature. In summary, the present data suggest that using a temperature of 438C is not associated with a decreased electrode performance for TcPCO 2 measurements, although decreasing probe temperature is associated with a prolonged response time (16) . Interestingly, optimal performance (i.e. TcPCO 2 -PaCO 2 gradient within bias+2 mmHg) of the capnograph was in the 40-54 mmHg range (i.e. in a normal to moderate hypercapnia range: 
CLINICAL VALUE OF TcPO 2
As previously described (17) , and with the exception of the study by Sringhar et al. Although widely used in neonatal and infant monitoring, in an adult population, pulse oximetry is far more reliable than TcPO 2 monitoring (1,2). In fact, in adults, the strong influence of cutaneous blood flow on TcPO 2 has led to the use of TcPO 2 monitoring as a measure of local perfusion rather than an estimate of arterial PaO 2 (2).
DRIFT OF TcPCO 2 SIGNAL OVER TIME AND TOLERANCE TO PROLONGED CONTINUOUS MEASURING
There are few reports measuring the drift of the TcPCO 2 signal in a clinical setting (3, 5, 9, 18, 19) . Reported TcPCO 2 signal drift ranges from non-significant to 1 mmHg h 71 . Tolerance to continuous TcPCO 2 measurement has been previously reported for up to 5 h at 438C, using a Radiometer Tina TCM3 Capnograph (9) , and up to 6 h, using a Kontron capnograph, without any local side-effects (5). Mahutte et al. (18) recorded TcPCO 2 for 8 h at 43?58C in 47 adult patients: mild erythema was frequent, resolving after 24-48 h; blisters developed in three patients (in whom the sensor had been left inadvertantly in place for more than 8 h). A temperature of 438C therefore appears to be the highest recommendable electrode temperature for a safe 6-8 h monitoring.
Despite the results presented, some important caveats must be kept in mind when using transcutaneous CO 2 monitoring: there is a clear possibility of impredictable errant values; occasional unexplained fluctuations in TcPCO 2 occur without any clear technical explanation (although this was not the case in the patients studied, it is an occasional occurrence in current clinical practice) one must also bear in mind the lag time of transcutaneous measurements (average 5+3 min) which precludes the recording of brief ventilatory events such as obstructive apneas (3); regular recalibration and changing of probe membrane are mandatory for optimal transcutaneous signals; also, transcutaneous measurements are adversely affected by cutaneous vasoconstriction due to hypovolaemic or cardiogenic hypotension, vasoconstricting agents, and hypothermia which all markedly increase the TcPCO 2 -PaCO 2 gradient (2). Noteworthy is the fact that none of the patients studied in this report were haemodynamically unstable or receiving vasopressor treatment. In summary, our results show that continuous monitoring of TcPCO 2 for up to 8 h, at a probe temperature of 438C, is well tolerated in patients during NIV, and is not associated with a significant drift of the TcPCO 2 signal, or a decrease in electrode performance. The range of optimal performance of the electrode (40-54 mm Hg) is quite suitable for adjusting and monitoring NIV. However, these results apply only for adults and for the monitor tested. Taking into account the above-mentioned caveats and limitations, TcPCO 2 is a reliable method of continuous monitoring of NIV, of estimating the average impact of NIV on nocturnal PaCO 2 , and documenting periods of hypoventilation lasting more than a few minutes.
